Veterinary Medicine Information website

RUVAX

Not authorised
  • Erysipelothrix rhusiopathiae, serotype 2, Inactivated

Product identification

Medicine name:
RUVAX
Active substance:
  • Erysipelothrix rhusiopathiae, serotype 2, Inactivated
Target species:
  • Pig (for fattening)
  • Pig (for reproduction)
  • Turkey
  • Sheep (ewe)
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Erysipelothrix rhusiopathiae, serotype 2, Inactivated
    1.00
    enzyme-linked immunosorbent assay unit
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig (for fattening)
      • All relevant tissues
        0
        day
    • Pig (for reproduction)
      • All relevant tissues
        0
        day
  • Subcutaneous use
    • Turkey
      • All relevant tissues
        0
        day
    • Pig (for reproduction)
      • All relevant tissues
        0
        day
      • All relevant tissues
        0
        day
    • Sheep (ewe)
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01CB02
  • QI04AB08
  • QI09AB03
Authorisation status:
  • Surrendered
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France SCS
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/2390009 1/1985
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022